Indoco Remedies shares jump 18% after UK-MHRA clears Goa plant
Indoco Remedies said the UK Medicines and Healthcare Products Regulatory Agency (UK-MHRA) concluded its inspection of its Goa manufacturing facility with no critical or major observations. The shares rose, reaching an intraday high of ₹269.90, up 17.9%.
Indoco Remedies shares surged on Thursday after the company said the UK Medicines and Healthcare Products Regulatory Agency (UK-MHRA) completed its inspection of the Goa manufacturing facility without any critical or major observations. 9% from the previous close.